{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Baltimore",
      "address_1": "Harborplace Tower",
      "reason_for_recall": "Presence of Foreign substance: identified as a dead ant.",
      "address_2": "111 S Calvert St Fl 21st",
      "product_quantity": "28,254 bottles",
      "code_info": "Lot #: F802436, F802437, F802438, F802442, Exp 11/20",
      "center_classification_date": "20191107",
      "distribution_pattern": "Product was distributed to major distributors/wholesalers throughout the United States.",
      "state": "MD",
      "product_description": "Cephalexin for Oral Suspension USP, 250 mg/5mL, 200 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mumbai 400 098 INDIA, NDC 68180-0441-02",
      "report_date": "20191113",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Lupin Pharmaceuticals Inc.",
      "recall_number": "D-0304-2020",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "84196",
      "termination_date": "20210304",
      "recall_initiation_date": "20191101",
      "postal_code": "21202-6174",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}